QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy

Author： LLerena Adrián   Berecz Roland   Rubia Alfredo   Dorado Pedro  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.58, Iss.3, 2002-06, pp. : 223-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Examination of Baseline Risk Factors for QTc Interval Prolongation in Patients Prescribed Intravenous Haloperidol

By Muzyk Andrew J.   Rayfield Amber  

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 547-553

Adis International

Access to resources Recommend Favorite

Metoprolol reduces the QTc interval but does not change QTc dispersion in patients with type 1 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Antipsychotics and Old Age Predict QTc Elongation in Acute Hospitalized Psychiatric Patients

By  

Current Psychopharmacology, Vol. 4, Iss. 1, 2015-04 ,pp. : 27-39

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotine Decreases Bradykinesia-rigidity in Haloperidol-treated Patients with Schizophrenia

By Yang Y.K.   Nelson L.   Kamaraju L.   Wilson W.   McEvoy J.P.  

Neuropsychopharmacology, Vol. 27, Iss. 4, 2002-10 ,pp. : 684-686

Elsevier

Access to resources Recommend Favorite

Haloperidol: Tardive dyskinesia in elderly patients, treated with aripiprazole: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite